An inhibitor of the USP1-UAF1 complex and SARS-CoV-2 PLpro
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

SJB2-043

Item No. 36605

Technical Information
Formal Name
2-phenyl-naphth[2,3-d]oxazole-4,9-dione
CAS Number
63388-44-3
Molecular Formula
C17H9NO3
Formula Weight
Purity
≥98%
Formulation
A solid
DMF: 2 mg/mlDMSO: 1 mg/mlEthanol: insolPBS (pH 7.2): insol
λmax
277 nm
SMILES
O=C1C2=C(C(C3=C1C=CC=C3)=O)OC(C4=CC=CC=C4)=N2
InChi Code
InChI=1S/C17H9NO3/c19-14-11-8-4-5-9-12(11)15(20)16-13(14)18-17(21-16)10-6-2-1-3-7-10/h1-9H
InChi Key
CMYQQADDUUDCCA-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    SJB2-043 is an inhibitor of the ubiquitin-specific peptidase 1 (USP1) and USP1-associated factor 1 (UAF1) complex (USP1-UAF1 complex; IC50 = 0.544 µM for its deubiquitinase activity) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) papain-like protease (PLpro).1,2 It reduces the levels of USP1, DNA-binding protein inhibitor 1 (ID-1), ID-2, and ID-3 in K562 chronic myelogenous leukemia (CML) cells when used at concentrations ranging from 0.5 to 10 µM, an effect that can be partially blocked by the proteasome inhibitor MG132.1 SJB2-043 decreases the viability of K562 cells (EC50 = 1.07 µM) and induces apoptosis in K562 cells in a concentration-dependent manner. It also inhibits SARS-CoV-2 PLpro with IC50 values of 0.56 and 0.091 µM using the fluorogenic substrates Z-LRGG-AMC (Item No. 26641) or ubiquitin-AMC (Ub-AMC), respectively, as PLpro substrates.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Mistry, H., Hsieh, G., Buhrlage, S.J., et alSmall-molecule inhibitors of USP1 target ID1 degradation in leukemic cells. Mol. Cancer Ther. 12(12), 2651-2662 (2013).

    2. Cho, C.-C., Li, S.G., Lalonde, T.J., et alDrug repurposing for the SARS-CoV-2 papain-like protease. ChemMedChem 17(1), e202100455 (2022).